NanoString Technologies Inc.

280 articles about NanoString Technologies Inc.

• Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics

  6/8/2023

  Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology.

• Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells

  6/1/2023

  Owkin, Nanostring, and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, and Charité - Universitätsmedizin Berlin are launching MOSAIC at the American Society of Clinical Oncology’s annual meeting.

• NanoString to Webcast Presentation from Jefferies 2023 Healthcare Conference

  5/31/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023.

• NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich

  5/22/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich.

• NanoString Technologies Releases Operating Results for First Quarter of 2023

  5/3/2023

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2023.

• NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023

  4/10/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023.

• NanoString Reports Inducement Grants Under Nasdaq Listing Rules - March 08, 2023

  3/8/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16 new employees.

• NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference

  3/1/2023

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43rd Annual Cowen Health Care Conference.

• NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook

  2/28/2023

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022.

• NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference

  2/23/2023

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference.

• NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023

  2/14/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023.

• NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)

  2/6/2023

  NanoString Technologies, Inc. today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL.

• Weill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy

  2/2/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy initiative, in collaboration with Weill Cornell Medicine, to create multicellular, single-cell, and sub-cellular maps of 30 non-diseased organs from a healthy and diverse population of adults.

• NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager

  1/19/2023

  NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new data generated by the CosMx™ Spatial Molecular Imager (SMI).

• NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022

  1/8/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2022.

• NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference

  12/22/2022

  NanoString Technologies, Inc. today announced that the company’s management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference.

• NanoString’s CosMx Spatial Molecular Imager Recognized by The Scientist Magazine as a Top 10 Innovation of 2022

  12/13/2022

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the company’s CosMx™ Spatial Molecular Imager has been recognized by The Scientist magazine as one of the Top 10 Innovations of the 2022.

• NanoString Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform

  12/6/2022

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the first commercial shipment of the CosMx™ Spatial Molecular Imager and the AtoMx™ Spatial Informatics Platform.

• NanoString to Webcast Presentations from Two Upcoming November 2022 Healthcare Conferences

  11/10/2022

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.

• NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research

  11/9/2022

  NanoString Technologies, Inc. and Abcam announced the expansion of their long-standing relationship with a new agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomic solutions.